InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| C14-Tri-LAN-Gly | NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... | 2021 | Front Immunol. | Jia F. et al. | DOI: 10.3389/fimmu.2021.603192 |
| Blasticidin | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| QUANTI-Blue™ | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| Zeocin® | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| IFN-α/β Reporter HEK 293 Cells | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
| Pyroptosis & Necroptosis Cellular Reporter Assay | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| QUANTI-Blue™ | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| Pam3CSK4 | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| QUANTI-Luc™: Luciferase Detection Reagent | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| HEK-Blue™ Selection | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| LPS-B5 (LPS from E. coli O55:B5) | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
| THP1-Blue™ ISG Cells | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |
| 3'3'-cGAMP | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |
| c-di-GMP | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |
| 2'3'-cGAMP | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |
| DMXAA | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |
| Puromycin | Myogenin suppresses apoptosis induced by angiotensin II in human induced plur... | 2021 | Biochem Biophys Res Commun. | Gao Q. et al. | DOI: 10.1016/j.bbrc.2021.03.031 |
| Primocin® | Exploring the human lacrimal gland using organoids and single-cell sequencing. | 2021 | Cell Stem Cell. | Bannier-Hélaouët M. et al. | DOI: 10.1016/j.stem.2021.02.024 |
| ODN 2006 (ODN 7909) | Autologous hematopoietic stem cell transplantation restores the suppressive c... | 2021 | Rheumatology (Oxford). | Lima-Júnior J.R. et al. | DOI: 10.1093/rheumatology/keab257 |